Terms: = Prostate cancer AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2 AND Diagnosis
5 results:
1. Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancer.
Ravi P; Freeman D; Thomas J; Ravi A; Mantia C; McGregor BA; Berchuck JE; Epstein I; Budde P; Ahangarian Abhari B; Rupieper E; Gajewski J; Schubert AS; Kilian AL; Bräutigam M; Zucht HD; Sonpavde G
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38309723
[TBL] [Abstract] [Full Text] [Related]
2. Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials.
Vale CL; Fisher DJ; Godolphin PJ; Rydzewska LH; Boher JM; Burdett S; Chen YH; Clarke NW; Fizazi K; Gravis G; James ND; Liu G; Matheson D; Murphy L; Oldroyd RE; Parmar MKB; Rogozinska E; Sfumato P; Sweeney CJ; Sydes MR; Tombal B; White IR; Tierney JF;
Lancet Oncol; 2023 Jul; 24(7):783-797. PubMed ID: 37414011
[TBL] [Abstract] [Full Text] [Related]
3. Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.
Keegan NM; Vasselman SE; Barnett ES; Nweji B; Carbone EA; Blum A; Morris MJ; Rathkopf DE; Slovin SF; Danila DC; Autio KA; Scher HI; Kantoff PW; Abida W; Stopsack KH
Prostate; 2022 Aug; 82(11):1107-1116. PubMed ID: 35538298
[TBL] [Abstract] [Full Text] [Related]
4. Germline genetic variants in men with prostate cancer and one or more additional cancers.
Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
[TBL] [Abstract] [Full Text] [Related]
5. [Markers for non-invasive molecular genetic diagnosis of oncourological diseases].
Mikhaĭlenko DS; Perepechin DV; Apolikhin OI; Efremov GD; Sivkov AV
Urologiia; 2014; (5):116-20. PubMed ID: 25807773
[TBL] [Abstract] [Full Text] [Related]
